Poor people who have cancer are one of the most financially vulnerable groups in the US. Obamacare aimed to improve their access to care. A recent study shows how it did.
Academic rigor, journalistic flair
Articles on Cancer treatment
Displaying 41 - 60 of 84 articles
A new study shows that anal cancer, caused by the virus HPV, can be successfully fought in HIV-positive men by timely treatment and HPV vaccination of lesions that may ultimately lead to cancer.
Men diagnosed with prostate cancer should be given all their options for treatment before they make a decision. In Australia today, this isn’t the rule, but the exception.
Imagine being able to offer hope to people with cancers once thought untreatable. Checkpoint immune drugs like Opdivo and Keytruda lead this new era in treatment. But they don’t work for everyone.
The high cost of cancer drugs in South Africa has come under the spotlight with an investigation by the Competition Commission in the country.
Successful policy interventions, especially those in the social realm influenced by the vagaries of human behaviour, don’t seem to travel well.
Nanoparticles are a form of transport for drugs and can go places drugs wouldn’t be able to go on their own. They make drug delivery more targeted, reducing collateral damage to healthy tissues.
The composition of bacteria in our gut regulates our immune system. Modifying it - through poo transplants for example - can control cancer risk, as well as response to treatment.
Getting the right amount of radiation is a fine balance between therapy and harm. A common way to improve the benefit-to-cure ratio is to fire multiple beams at the tumour from different directions.
Rare diseases may only affect a handful of people but their treatment benefits everyone.
It’s early days, but hope is on the horizon when it comes to one of the deadliest cancers.
In Australia, there is no system in place to support people returning to work after cancer treatment – or to provide advice to their employers on how to help them.
Research in animals and humans shows periods of fasting before and after chemotherapy protects healthy cells while killing cancerous ones more efficiently.
If you’re an Australian teenager or young adult diagnosed with cancer, there’s good news: overall survival rates are good and getting better. But what can you expect from life after cancer treatment?
The well-used drug clomipramine could target tumour cells and leave normal cells healthy – if scientists could get enough evidence for it.
By measuring a cancer cell’s DNA in the bloodstream, scientists can get a snapshot of the cancer itself, which is referred as a “liquid biopsy”.
One in ten cancer patients will face fertility issues after treatment, but less than 50% are given options to preserve fertility. And those who are offered options can face significant cost barriers.
What started with a study of diseases transmitted by mosquitos, could end with a new way of treating cancer.
Humans can more easily tolerate tumours in large or paired organs than in small, critical ones. This could be why the latter have evolved more cancer-fighting mechanisms.
Infectious diseases have plagued Africa for decades. Now, Africa faces the threat of a cancer pandemic – with a shortage of equipment, doctors and money to treat it.
Top contributors
-
Associate Professor of the Sydney Pharmacy School, University of Sydney
-
Professorial Research Fellow. School of Psychology, Faculty of Health and Medical Sciences, University of Adelaide
-
NHMRC Senior Research Fellow, Centre for Cancer Biology, University of South Australia
-
University Distinguished Professor of Marketing, Mays Business School; Senior Fellow, Institute for Healthcare Improvement, Texas A&M University
-
Professor of Exercise Medicine, Edith Cowan University
-
Veronique Chachay is a Friend of The Conversation.
Research & Teaching Academic, The University of Queensland
-
Professor of Health Economics, Deputy Director of CHERE, University of Technology Sydney
-
Professor of Health Economics, University of Technology Sydney
-
Professor of Behavioural Ecology, UCL
-
Chancellor's Professor of Medicine, Liberal Arts, and Philanthropy, Indiana University
-
Lecturer in Robotics, University of Bristol
-
Associate Professor, Cornell University
-
Professor of Experimental Cancer Therapeutics, Institute of Cancer Research, London
-
Lecturer in Speech Pathology, The University of Queensland
-
Dean, Graduate Research, University of Canberra
